Prognostic Implication of Plasma Metabolites in Gastric Cancer
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Gastric cancer (GC) typically carries a poor prognosis as it is often diagnosed at a late stage. Altered metabolism has been found to impact cancer outcomes and affect patients’ quality of life, and the role of metabolites in gastric cancer prognosis has not been sufficiently understood. We aimed to establish a prognostic prediction model for GC patients based on a metabolism-associated signature and identify the unique role of metabolites in the prognosis of GC. Thus, we conducted untargeted metabolomics to detect the plasma metabolites of 218 patients with gastric adenocarcinoma and explored the metabolites related to the survival of patients with gastric cancer. Firstly, we divided patients into two groups based on the cutoff value of the abundance of each of the 60 metabolites and compared the differences using Kaplan–Meier (K-M) survival analysis. As a result, 23 metabolites associated with gastric cancer survival were identified. To establish a risk score model, we performed LASSO regression and Cox regression analysis on the 60 metabolites and identified 8 metabolites as an independent prognostic factor. Furthermore, a nomogram incorporating clinical parameters and the metabolic signature was constructed to help individualize outcome predictions. The results of the ROC curve and nomogram plot showed good predictive performance of metabolic risk features. Finally, we performed pathway analysis on the 24 metabolites identified in the two parts, and the results indicated that purine metabolism and arachidonic acid metabolism play important roles in gastric cancer prognosis. Our study highlights the important role of metabolites in the progression of gastric cancer and newly identified metabolites could be potential biomarkers or therapeutic targets for gastric cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Eight metabolites (ornithine, phenyl acetyl-L-glutamine, porphobilinogen, linoleic acid, DL-dipalmitoyl phosphatidylcholine, 5′-mdthylthioadenosine, inosine triphosphate, and paraxanthine) were indicated as an independent prognostic factor of GC by the forest plot of the Cox regression analysis.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study screening GC survival-associated metabolites identified 24 metabolites by using Kaplan–Meier survival analysis [58].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Enrichment analysis found that purine metabolism and linoleic acid metabolism were found to be the most significant metabolic pathways related to the survival of patients with GC.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803 · cited 2×
“Gastric cancer (GC) is one of the most prevalent causes of cancer-related deaths worldwide [1].”
BackgroundPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“SM(d18:1/16:0), DL-dipalmitoylphosphatidylcholine, and Cer(d18:0/12:0) all belong to sphingolipids [28].”
BackgroundThe Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
How To Build and Interpret a Nomogram for Cancer Prognosis
Iasonos, A., Schrag, D., Raj, G. V., & Panageas, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9791 · Cited by 3,222 · cited 1×
“Owing to their intuitive visual presentation and personalized application, nomograms have become a popular tool for oncology prognosis [7,21].”
MethodImmune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345 · cited 1×
“Targeted programmed cell death-ligand 1(PD-L1) can promote lipid uptake by Trm cells, increase their survival rate, improve patient outcomes, and have promoted the mode transformation of cancer treatment [15].”
BackgroundUnderstanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293 · cited 1×
“The blocking of these pathways or restoration of altered metabolic pathways has been proven to be promising therapeutic target strategies [7,8].”
BackgroundCancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824 · cited 1×
“There is growing evidence that reprogrammed cellular metabolism supports tumorigenesis, progression, metastasis, and drug resistance [5,6].”
BackgroundGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651 · cited 1×
“A variety of lipid metabolites in tumor cells can also be targeted for cancer therapy [24].”
BackgroundSphingolipid metabolism in cancer signalling and therapy
Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207
Cited by
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“A study screening GC survival-associated metabolites identified 24 metabolites by using Kaplan–Meier survival analysis [58].”
MethodZhang, C., Hu, Z., Pan, Z., Ji, Z., Cao, X., Yu, H., Qin, X. Y., & Guan, M. (2024) · The Analyst · doi:10.1039/d3an01723k · Cited by 18
Choi, S. J., Choi, H. S., Kim, H., Lee, J. M., Kim, S. H., Yoon, J. H., Keum, B., Kim, H. J., Chun, H. J., & Park, Y. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179509 · Cited by 13
“Cao et al. recently performed a pathway analysis using plasma metabolites and proposed that purine and arachidonic acid metabolism may play important roles in GC progression [38].”
BackgroundWang, T., & Gao, Y. (2023) · MedComm – Future Medicine · doi:10.1002/mef2.59 · Cited by 7
Exploring the Prognosis-Related Genetic Variation in Gastric Cancer Based on mGWAS
Zhang, Y., Lyu, Y., Chen, L., Cao, K., Chen, J., He, C., Lyu, X., Jiang, Y., Xiang, J., Liu, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015259 · Cited by 5
Self-citation
Metadata
- Authors
- Cao, K., Lyu, Y., Chen, J., He, C., Lyu, X., Zhang, Y., Chen, L., Jiang, Y., Xiang, J., Liu, B., & Wu, C.
- Affiliations
- Fujian Medical University (CN)
- Corresponding author
- Wu, Chuancheng
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-08-14
- Volume
- 24
- Issue
- 16
- Pages
- 12774
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10454100
- OpenAlex
- W4385805803
- Cited by
- 16
- References
- 54
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Fujian Natural Science Foundation (2015J01673, 2017J01811)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- gastric cancer, plasma metabolites, prognostic factors, untargeted metabolomics, metabolic signatures, survival prediction, risk scoring, nomogram, purine metabolism, arachidonic acid metabolism, gastric adenocarcinoma
- MeSH terms
- Humans, Prognosis, Quality of Life, Stomach Neoplasms, Nomograms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic Implication of Plasma Metabolites in Gastric Cancer. https://app.cochat.ai/papers/10.3390/ijms241612774
- The paper
- Cao, K., Lyu, Y., Chen, J., He, C., Lyu, X., Zhang, Y., Chen, L., Jiang, Y., Xiang, J., Liu, B., & Wu, C. (2023). Prognostic Implication of Plasma Metabolites in Gastric Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241612774
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.